196 related articles for article (PubMed ID: 35421267)
1. Constructing an immune- and ferroptosis-related lncRNA signature to predict the immune landscape of human bladder cancer.
Li X; Zhou L; Lu T; Zhang L; Li Y; Xu J; Yin M; Long H
J Clin Lab Anal; 2022 May; 36(5):e24389. PubMed ID: 35421267
[TBL] [Abstract][Full Text] [Related]
2. Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response.
Liu J; Zhang Z; Liu X; Zhang W; Meng L; Wang J; Lv Z; Xia H; Zhang Y; Wang J
World J Surg Oncol; 2022 Feb; 20(1):47. PubMed ID: 35209909
[TBL] [Abstract][Full Text] [Related]
3. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
[TBL] [Abstract][Full Text] [Related]
4. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer.
Lu H; Wu J; Liang L; Wang X; Cai H
Front Immunol; 2022; 13():803355. PubMed ID: 35154117
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
Front Immunol; 2022; 13():922315. PubMed ID: 35774794
[TBL] [Abstract][Full Text] [Related]
6. Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer.
Zhou R; Liang J; Tian H; Chen Q; Yang C; Liu C
Dis Markers; 2021; 2021():1031906. PubMed ID: 34239619
[TBL] [Abstract][Full Text] [Related]
7. Integrated clinical characteristics and omics analysis identifies a ferroptosis and iron-metabolism-related lncRNA signature for predicting prognosis and therapeutic responses in ovarian cancer.
Feng S; Yin H; Zhang K; Shan M; Ji X; Luo S; Shen Y
J Ovarian Res; 2022 Jan; 15(1):10. PubMed ID: 35057848
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.
Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K
Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
11. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
Xu M; Li Q; Zhang J; Xie H
Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
[TBL] [Abstract][Full Text] [Related]
12. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
13. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
14. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
15. Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer.
Lin Y; Gan F; He X; Deng H; Li Y
J Immunol Res; 2022; 2022():5893998. PubMed ID: 35915656
[TBL] [Abstract][Full Text] [Related]
16. Construction of an immune-related LncRNA signature with prognostic significance for bladder cancer.
Luo WJ; Tian X; Xu WH; Qu YY; Zhu WK; Wu J; Ma CG; Zhang HL; Ye DW; Zhu YP
J Cell Mol Med; 2021 May; 25(9):4326-4339. PubMed ID: 33797188
[TBL] [Abstract][Full Text] [Related]
17. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
Bao Z; Zhang W; Dong D
Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma.
Ju L; Shi Y; Liu G
PeerJ; 2022; 10():e14506. PubMed ID: 36570012
[TBL] [Abstract][Full Text] [Related]
19. Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Zhou Z; Yang Z; Cui Y; Lu S; Huang Y; Che X; Yang L; Zhang Y
Front Genet; 2022; 13():787884. PubMed ID: 35350243
[No Abstract] [Full Text] [Related]
20. An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
Qian L; Ni T; Fei B; Sun H; Ni H
BMC Cancer; 2022 May; 22(1):545. PubMed ID: 35568824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]